NCT02369250View on ClinicalTrials.gov

Rosuvastatin Gel With 1:1 Mixture of Platelet-rich Fibrin and Bone Graft in Mandibular Degree II Furcation Defects

PHASE4CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

September 30, 2014

Conditions

Furcation Defects

Interventions

DRUG

Rosuvastatin

Rosuvastatin, is a statin group of drug.

BIOLOGICAL

platelet rich fibrin

AUTOLOGUS PLATELET GROWTH FACTOR

All Listed Sponsors

lead

Government Dental College and Research Institute, Bangalore

OTHER

NCT02369250 - Rosuvastatin Gel With 1:1 Mixture of Platelet-rich Fibrin and Bone Graft in Mandibular Degree II Furcation Defects | Biotech Hunter | Biotech Hunter